SCHEMBL807770

SCHEMBL807770

CCc1cc(N2CCOCC2)nc(C)n1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.56
KMT2A Q03164 3/20 0.51
CRHBP P24387 2/20 0.50
CRHR2 Q13324 2/20 0.50
ALDH1A1 P00352 2/20 0.46
HPGD P15428 2/20 0.46
GAA P10253 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HRH4 Q9H3N8 1/20 0.46
KDM4E B2RXH2 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
LMNA P02545 1/20 0.45
CYP1A2 P05177 2/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
MTOR P42345 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HTT P42858 2/20 0.43
CYP2D6 P10635 1/20 0.43
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11981646 0.85 KMT2A (0.47) POLBKMT2ACRHBPCRHR2HRH4
SCHEMBL12110343 0.84 KMT2A (0.51) KMT2ACRHBPCRHR2ALDH1A1HPGD
SCHEMBL1271706 0.83 ALDH1A1 (0.56) POLBKMT2ACRHBPCRHR2ALDH1A1
SCHEMBL1270763 0.83 KMT2A (0.64) POLBKMT2ACRHBPCRHR2ALDH1A1
SCHEMBL28205073 0.83 CRHBP (0.65) POLBKMT2ACRHBPCRHR2HRH4
SCHEMBL22457644 0.81 CASP1 (0.47) POLBKMT2AALDH1A1HPGDHRH4
SCHEMBL5788649 0.80 KMT2A (0.72) POLBKMT2ACRHBPCRHR2ALDH1A1
SCHEMBL24766561 0.79 KMT2A (0.49) POLBKMT2ACRHBPCRHR2ALDH1A1
Ammonia Solution, Strong SCHEMBL28615378 0.78 KMT2A (0.70) POLBKMT2ACRHBPCRHR2ALDH1A1
SCHEMBL10272785 0.77 KMT2A (0.75) POLBKMT2AALDH1A1NPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013041539-A1 IMIDAZOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE F. HOFFMANN-LA ROCHE AG (CH) 2013-03-28 WO disclosed
WO-2012035039-A1 AZABENZOTHIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE F. HOFFMANN-LA ROCHE AG (CH) 2012-03-22 WO disclosed